NCT02465268 2025-01-14
ATTAC-II
University of Florida
Phase 2 Completed
Clinical Trials
5 trialsNCT00639639 2023-03-13
ATTAC
Duke University
Phase 1 Completed
NCT01644968 2022-05-17
Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer
Providence Health & Services
Phase 1 Completed
NCT02747407 2021-10-29
Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors
Wake Forest University Health Sciences
Completed
NCT01611298 2020-04-21
TAR
Baylor College of Medicine
Phase NA Completed